Kedudukan dalam Saham
#38016
Evgen Pharma plc, a UK-based pharmaceutical company founded in 2014, operates... Evgen Pharma plc, a UK-based pharmaceutical company founded in 2014, operates at the clinical development stage, concentrating on the creation of sulforaphane-based medications. Its mission is to combat various cancers and inflammatory conditions. The firm utilizes its proprietary Sulforadex technology, which is engineered to stabilize sulforaphane, in its product development. SFX-01 stands as their principal drug candidate, currently in Phase II clinical trials for metastatic breast cancer and Phase Ib/IIa trials for glioblastoma. Furthermore, SFX-01 is being investigated in preclinical stages for haematological malignancies and analogous disorders. The company also offers out-licensing services for its innovative technology.
Harga Saham
$0.00953895
Disegerakkan terakhir: 2024-05-22
Perubahan (1 tahun)
0.00%
Perdagangan Evgen Pharma plc (EVG)
Harga EVG dengan permodalan pasaran b
Modal pasaran bagi Evgen Pharma plc(EVG)
Modal Pasaran: $1.28M
Sehingga August 2026, Evgen Pharma plc mempunyai modal pasaran sebanyak $1.28M. Ini menjadikan Evgen Pharma plc syarikat ke-38016th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran Evgen Pharma plc dari 2015 hingga 2026
EVG berbanding dengan 5 teratas yang paling popular stocks
| Harga EVG |
|
Aset B |
Pasaran B |
Hasilnya |
|
|
|
|
$5.452T
|
+424,564,517.03%
|
|
|
|
|
$4.490T
|
+349,660,564.35%
|
|
|
|
|
$4.162T
|
+324,147,665.18%
|
|
|
|
|
$3.676T
|
+286,295,348.85%
|
|
|
|
|
$2.833T
|
+220,623,311.32%
|
